Chronic liver diseases result from a range of metabolic or inflammatory dysfunctions, often associated with unhealthy lifestyle or continuous alcohol consumption. In the manifestation of chronic liver diseases, the deposition of lipid droplets in liver tissue (steatosis) contributes significantly to the proinflammatory milieu (steatohepatits) and leads to portal hypertension and fibrosis (cirrhosis). The underlying immune response as well as the resulting cell-cell interactions are still poorly understood.
In this webinar, Nico Kraus, clinical research associate at University Hospital Frankfurt, will highlight the differences between the various stages of chronic liver disease in animal models. Using the Cellscape Ultra High 17-Plex Immuno Panel on OCT murine liver tissue, Kraus and colleagues identified cell-cell interactions responsible for altering the immune response and metabolic changes in newly designed mouse models by spatio-temporal analysis.
Canopy Biosciences is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
I agree to receive marketing communications from Canopy Biosciences.
You can unsubscribe from these communications at any time by clicking the Unsubscribe link at the bottom of any of the emails we've sent you. View our Privacy Policy for more information.
By clicking submit below, you consent to allow Canopy Biosciences to store and process the personal information submitted above to provide you the content requested.